Morning Movers
Gapping up
$DoorDash (DASH.US)$ stock rose 0.4% after CFRA Research upgraded its investment stance on the food delivery platform to buy from hold, citing its high growth potential.
$Roivant Sciences (ROIV.US)$ stock rose 7.2% after the biotech said its experimental drug to treat non-infectious uveitis helped reduce symptoms of the inflammatory eye disease in a mid-stage study.
Gapping down
$NIO Inc (NIO.US)$ fell ...

$HeartSciences (HSCS.US)$ squeez up pls

$HeartSciences (HSCS.US)$ T2 Biosystems Receives FDA 510(k) Clearance for the T2Biothreat Panel

$Alterity Therapeutics (ATHE.US)$ It's time to take off